Member of the Board and member of the Audit Committee
Andreas Fibig is chairman of the board and chief executive officer of International Flavors & Fragrances Inc., based in the US.
From 2008 to 2014, Mr Fibig was president and chairman of the board of management of Bayer HealthCare Pharmaceuticals, a division of Bayer AG, Germany. Previously, Mr Fibig held several positions of increasing responsibility at Pfizer, Inc., US, including the roles as senior vice president of the US Pharmaceutical Operations from 2007 to 2008; and as president of Latin America, Africa and Middle East from 2003 to 2007. Prior to that, Mr Fibig served as market company president at Pharmacia Corporation in Germany from 2000 to 2003. From 1984 until 1999, Mr Fibig held a series of leadership positions at Boehringer Ingelheim GmbH, Germany.
Mr Fibig is member of the board of the German American Chamber of Commerce and executive director of the World Council for Sustainable Development.
Mr Fibig holds a degree
in Marketing from Berlin School of Economics, Germany, from 1982.
Mr Fibig was first
elected to the Board of Novo Nordisk A/S in March 2018. His term as
a board member expires in March 2019.
In March 2018, the Board of Directors of Novo Nordisk A/S assessed that Mr Fibig is regarded as an independent board member as defined in Section 3.2.1 of the Recommendations on Corporate Governance designated by Nasdaq Copenhagen.
Mr Fibig became member of the Audit Committee at Novo Nordisk A/S in March 2018. In March 2018, the Board of Directors of Novo Nordisk A/S assessed that Mr Fibig qualifies as independent pursuant to the US Securities Exchange Act.
In January 2018, the Board of Directors assessed that the special competences possessed by Mr Fibig that are important for the performance of his duties are his extensive global experience within biopharmaceutical companies, in-depth knowledge of strategy, sales and marketing and knowledge about how large international companies operate.
Mr Fibig is a male German national, born February 1962.